kras
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs
Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs
Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.





